Clinical trials, including the RADIANCE series, have shown consistent effectiveness of ultrasound renal denervation in lowering blood pressure, especially in patients who were previously unresponsive to anti-hypertensive medications. After a follow-up of 2months, mean ambulatory systolic blood pressure ...
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial - ScienceDirectEndovascular renal denervation reduces blood pressure in patients with mild-to-moderate hypertension, but its efficacy in ...
Paradise®Ultrasound Renal Denervation (RDN) Treatment Managing high blood pressure can be challenging. "Following my procedure with Paradise Ultrasound RDN, my blood pressure is better controlled." Candyce, 73 years old Whether you’ve been recently diagnosed with hypertension or had it for years,...
This sham-controlled, randomized clinical trial compares the efficacy and safety of ultrasound renal denervation vs a sham procedure without the
Credit: Lead Image: Science Photo Library/Getty Images Medscape Medical News © 2022 WebMD, LLC Send news tips tonews@medscape.net. Cite this: RADIANCE II: Positive Signal for Ultrasound Renal Denervation -Medscape- Jul 26, 2022.
Change in Ambulatory, Office, and Home Blood Pressure at 2 Months in the Ultrasound Renal Denervation Group (uRDN) and in the Sham Group in the Per-Protocol Population eTable 6. Change in Ambulatory, Office, and Home Blood Pressure at 2 Months in the Ultrasound Renal Denervation Group (uR...
The ultrasound-based Paradise system (ReCor Medical) for renal denervation significantly reduces daytime ambulatory systolic blood pressure at 2 months compared with a sham procedure in patients with mild-to-moderate hypertension, according to preliminary data from a clinical trial required for US ...
of Otsuka Holdings Co., Ltd., and its subsidiary ReCor Medical, Inc. announced the presentation of data from the RADIANCE-HTN SOLO trial demonstrating a durable blood pressure (BP)–lowering effect over 24 months for patients treated with Recor’s Paradise ultrasound renal ...
The results of the study, published inJAMA Cardiology,tested the device, which is used in an outpatient procedure called ultrasoundrenal denervation. The device is still investigational and has not yet been approved by the FDA for use outside ofclinical trials. ...
Targeting these nerves is not a new idea in hypertension treatment; several existing medications reduce renal nerve activity to reduce blood pressure. "But unlike medications, which are only effective when you take them, renal denervation is a therapy that's always 'on,'" Kirtane says. ...